A Pharmacokinetic Study Of The Combined Use Of Recombinant Human GH And IGF-1 In Children With Inflammatory Bowel (Crohn's) Disease.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Mecasermin (Primary) ; Somatrogon (Primary)
- Indications Short stature
- Focus Adverse reactions; Pharmacokinetics
- 04 Dec 2013 Status changed from recruiting to suspended as reported by United Kingdom Clinical Research Network record.
- 07 Apr 2013 Accrual to date is 16% according to United Kingdom Clinical Research Network.
- 07 Mar 2013 Accrual to date is 12% according to United Kingdom Clinical Research Network.